CH369129A - Method for introducing a hydroxyl group into the 12-position of Reichstein's compound S. - Google Patents
Method for introducing a hydroxyl group into the 12-position of Reichstein's compound S.Info
- Publication number
- CH369129A CH369129A CH6949459A CH6949459A CH369129A CH 369129 A CH369129 A CH 369129A CH 6949459 A CH6949459 A CH 6949459A CH 6949459 A CH6949459 A CH 6949459A CH 369129 A CH369129 A CH 369129A
- Authority
- CH
- Switzerland
- Prior art keywords
- compound
- reichstein
- mixture
- introducing
- hydroxyl group
- Prior art date
Links
- WHBHBVVOGNECLV-OBQKJFGGSA-N 11-deoxycortisol Chemical group O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 WHBHBVVOGNECLV-OBQKJFGGSA-N 0.000 title claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 title claims description 5
- 238000000034 method Methods 0.000 title claims description 5
- 239000000203 mixture Substances 0.000 claims description 10
- 238000000926 separation method Methods 0.000 claims description 4
- 150000003431 steroids Chemical class 0.000 claims description 4
- 241001312183 Coniothyrium Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 2
- 238000004810 partition chromatography Methods 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 230000021736 acetylation Effects 0.000 claims 1
- 238000006640 acetylation reaction Methods 0.000 claims 1
- 239000012736 aqueous medium Substances 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 10
- 229960000890 hydrocortisone Drugs 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- SUPOKHOQAKXOHJ-BYZMTCBYSA-N (8s,9s,10r,13r,14s,17s)-17-ethyl-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1CC2=CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](CC)[C@@]1(C)CC2 SUPOKHOQAKXOHJ-BYZMTCBYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 229960001031 glucose Drugs 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 235000010344 sodium nitrate Nutrition 0.000 description 2
- 239000004317 sodium nitrate Substances 0.000 description 2
- JYGXADMDTFJGBT-MKIDGPAKSA-N 11alpha-Hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-MKIDGPAKSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000004281 calcium formate Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229960001701 chloroform Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/06—Hydroxylating
- C12P33/08—Hydroxylating at 11 position
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/06—Hydroxylating
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Steroid Compounds (AREA)
Description
Verfahren zur Einführung einer Hydroxylgruppe in die 12-Stellung von Reichsteins Verbindung S Es ist bereits bekannt, dass man auf biochemi schem Wege Hydroxylgruppen als Substituenten an den verschiedensten Stellen in das Molekül von Ste- roiden einführen kann. Jedoch ist eine Einführung in die 12-Stellung allein auf diesem Wege bisher nicht beschrieben.
Man kennt lediglich eine gleichzeitige Einführung von Hydroxylgruppen in die 12- und 15- Stellung (vergleiche Chem. Ber., Band 90, 1957, Seite 2576 ff.) Es wurde nun gefunden, dass bei der Inkubation von Reichsteins Verbindung S (4-Pregnen-17a, 21 diol-3,20-dion) mit dem Pilz Coniothyrium hellebori, Rasse 078, aus der Klasse Fungi imperfecti und,
der Reihe Sphaeropsidales neben dem als Hauptprodukt in 50o/aiger Ausbeute entstehenden Hydrocortison (4-Pregne@n-11ss,17a-21-triol-3,20-dion) in mindestens 25 % iger Ausbeute auch 4-Pregnen-12ss,17a,21-triol- 3,20-dion gebildet wird.
Dieser Befund ist um so überraschender, als nach den Angaben der Britischen Patentschrift Nummer 749 414 bei der Inkubation des gleichen Ausgangs materials mit nahestehenden Pilzen der gleichen Klasse und Reihe als Nebenprodukt ausschliesslich 11-epi-Hydrocortison zu erwarten war.
Bei dem erfindungsgemässen Verfahren fallen Haupt- und Nebenprodukt der Kulturfiltratextrakte zunächst als kristallines Gemisch an. Seine vollstän dige Auftrennung durch Kristallisation ist schwierig und verlustreich. Acetyliert man das nicht weiter auf zutrennende Gemisch unter normalen milden Bedin gungen, so entstehen vorwiegend die Monoacetate beider Verbindungen, die sich ebenfalls nur schwer trennen lassen.
Acetyli.ert man dagegen das Gemisch bei höherer Temperatur, so bildet sich neben dem 21- Monoacetat des Hydrocortisons das 12ss,21-Diacetat des 4-Pregnen-12ss,17a-21-trio-3,20-dions. Die Tren- nung dieser Verbindung durch Kristallisation, Gegen stromverteilung oder Verteilungschromatographie be reitet nun keine Schwierigkeiten und gelingt praktisch quantitativ Das auf diese Weise rein erhältliche 4-Pregnen- 12ss,
17a - 21- triol - 3,20-dion-12ss,21-diacetat ist ein wertvolles Ausgangsprodukt für Synthesen in der Steroidreihe, insbesondere zur Herstellung pharma zeutisch interessanter Verbindungen.
<I>Beispiel</I> Es werden 2,41 einer Nährlösung hergestellt, die pro Liter folgende Bestandteile enthält: 50 g Dextrose, 10 g Biomalz, 2 g Natriumnitrat, 1 g prim. Kaliumphosphat, 0,5 g Kaliumchlorid, 0,5 g Magnesiumsulfat, 0,02 g Eisensulfat.
Je 1,2 1 der Lösung werden in einen Laborfer- menter von 2 1 Inhalt gegeben und hierin 30 Minuten bei 120 und 1 atü im Autoklaven sterilisiert. Die Fermenter bestehen aus einem Glasgefäss mit einem Deckel aus rostfreiem Stahl; sie sind ausgerüstet mit einem Turbinenrührer, Zugabestutzen, Lufteinlei- tungsrohr und Luftableitung.
Jeder Fermenter wird mit etwa 1 Milliarde Sporen des Coniothyrium helle- bori, Rasse 078, in Form einer wässrigen Suspension beimpft und dann 48 Stunden bei 25 mit 500 U. p. M. gerührt. Inzwischen wird in einem Stahlfermenter mit 50 1 Fassungsvermögen eine Lösung von 1,5 kg Dex trose, 30 g prim. Kaliumphosphat und 90 g Natrium nitrat in 30 1 Leitungswasser bereitet und diese 40 Minuten bei 120 und 1 atü sterilisiert.
Die Kulturen aus den beiden Laborfermentern werden steril ent nommen, gemischt und von der Mischung 1,6 1 zur Beimpfung des. 50-1=Fermenfiers verwendet.
Nach 24stündigem Rühren unter Durchleiten von 1-2 m3 Luft/Stunde (25 ) werden 5 g Reichsteins Verbindung S in 40 cm3 sterilem Dimethylformamid zugegeben.
Die gleiche Menge wird noch zweimal jeweils im Abstand von 24 Stunden zugesetzt. 24 Stunden nach der letzten Zugabe wird die Kultur dem Fermenter entnommen, filtriert und das Kulturfiltrat in einem Westfalia -Zentrifugalextraktor viermal mit je 41 Methylisobutylketon extrahiert.
Nach chromato- graphischer Analyse enthält der Extrakt 7,9g Hy- drocortison und 3,9 g 4-Pregnen-12ss,17a,21-triol- 3,20-dion.
Der Extrakt wird im Vakuum bis auf etwa 150 cm3 eingedampft. Beim Abkühlen kristallisiert die erste Fraktion aus, das Filtrat wird wieder ein gedampft und durch Kühlen weitere Kristallfraktionen gewonnen, die vereinigt und getrocknet werden.
Man erhält auf diese Weise 11 g eines Produktes, das 66 % Hydrocortison und 27 0/a 4-Pregnen-12ss, 17a,21-triol-3,20-dion enthält. Das Rohprodukt wird zweimal aus Äthylenchlorid, umkristallisiert, wodurch man 7 g chromatographisch reines Hydrocortison vom F. 212-2.15 erhält.
Die Mutterlaugen werden eingedampft und der Rückstand mit 10 em3 Pyridin aufgenommen, 5 cm3 Essigsäureanhydrid zugesetzt und das Gemisch 8 Stunden auf 50 erhitzt.
Das Reaktionsprodukt wird nach üblicher Aufarbeitung auf eine Säule gegeben, die 20 g mit Äthylenglykol imprägniertes Celite , das heisst eine unter diesem Handelsnamen bekannte Mischung verschiedener Kie selerden, enthält. Eluierung mit einem Gemisch aus 3 Teilen Cyclohexan und 1 Teil Methylenchlorid er gibt 3,5 g kristallines Material.
Durch Umkristalli- sieren aus wenig wässrigem Methanol erhält man 3 g 4 - Pregnen -12ss,17a,21- triol - 3,20 -dion-12ss,21-di- acetat. F. 155-157 ; E238 17 000; [a]D= + l22 (Chloro form).
Die Elementaranalyse bestätigt die Zusammen setzung der Verbindung. Der Mischschmelzpunkt mit einem authentischen, Präparat (J. Chem. Soc. <I>1955,</I> 870) gibt keine Depression. Die JR-Spektren beider Substanzen sind praktisch identisch.
Process for introducing a hydroxyl group into the 12-position of Reichstein's compound S It is already known that hydroxyl groups can be introduced as substituents in the most varied of positions in the molecule of steroids in a biochemical manner. However, an introduction to the 12-position in this way alone has not yet been described.
All that is known is a simultaneous introduction of hydroxyl groups in the 12- and 15-position (compare Chem. Ber., Volume 90, 1957, page 2576 ff.) It has now been found that when Reichstein's compound S (4-Pregnen -17a, 21 diol-3,20-dione) with the fungus Coniothyrium hellebori, breed 078, from the class Fungi imperfecti and,
of the Sphaeropsidales series, in addition to the hydrocortisone (4-pregne @ n-11ss, 17a-21-triol-3,20-dione), which is the main product in 50% yield, also 4-pregnen-12ss, 17a, 21-triol-3,20-dione is formed.
This finding is all the more surprising as, according to the information in British patent specification number 749 414, when the same starting material was incubated with related fungi of the same class and series, only 11-epi-hydrocortisone was to be expected as a by-product.
In the process according to the invention, the main product and by-product of the culture filtrate extracts are initially obtained as a crystalline mixture. Its complete separation by crystallization is difficult and lossy. If the mixture, which is not to be further separated, is acetylated under normal mild conditions, the monoacetates of both compounds are mainly formed, which are also difficult to separate.
On the other hand, if the mixture is acetylated at a higher temperature, the 12ss, 21-diacetate of 4-pregnene-12ss, 17a-21-trio-3,20-dione is formed in addition to the 21-monoacetate of hydrocortisone. The separation of this compound by crystallization, countercurrent distribution or partition chromatography does not present any difficulties and succeeds practically quantitatively. The 4-pregnen-12ss, which can be obtained in this way,
17a - 21-triol - 3,20-dione-12ss, 21-diacetate is a valuable starting product for syntheses in the steroid series, in particular for the production of pharmaceutically interesting compounds.
<I> Example </I> 2.41 of a nutrient solution are prepared which contains the following components per liter: 50 g dextrose, 10 g organic malt, 2 g sodium nitrate, 1 g prim. Potassium phosphate, 0.5 g potassium chloride, 0.5 g magnesium sulfate, 0.02 g iron sulfate.
1.2 l each of the solution are placed in a 2 l laboratory fermenter and sterilized in an autoclave for 30 minutes at 120 and 1 atm. The fermenters consist of a glass vessel with a stainless steel lid; They are equipped with a turbine stirrer, an addition nozzle, an air inlet pipe and an air outlet.
Each fermenter is inoculated with about 1 billion spores of Coniothyrium hellebori, breed 078, in the form of an aqueous suspension and then inoculated for 48 hours at 25 at 500 rpm. M. stirred. In the meantime, a solution of 1.5 kg dex trose, 30 g prime is in a steel fermenter with 50 l capacity. Potassium phosphate and 90 g sodium nitrate in 30 liters of tap water and sterilized for 40 minutes at 120 and 1 atm.
The cultures from the two laboratory fermenters are removed sterile, mixed and 1.6 l of the mixture used for inoculating the 50-1 = Fermenfier.
After stirring for 24 hours while passing through 1-2 m3 of air / hour (25), 5 g of Reichstein's compound S in 40 cm3 of sterile dimethylformamide are added.
The same amount is added two more times, each with an interval of 24 hours. 24 hours after the last addition, the culture is removed from the fermenter, filtered and the culture filtrate is extracted four times with 41% methyl isobutyl ketone in a Westfalia centrifugal extractor.
According to chromatographic analysis, the extract contains 7.9 g of hydrocortisone and 3.9 g of 4-pregnen-12ss, 17a, 21-triol-3,20-dione.
The extract is evaporated to about 150 cm3 in a vacuum. On cooling, the first fraction crystallizes out, the filtrate is evaporated again and further crystal fractions are obtained by cooling, which are combined and dried.
In this way, 11 g of a product are obtained which contain 66% hydrocortisone and 270 / a 4-pregnen-12ss, 17a, 21-triol-3,20-dione. The crude product is recrystallized twice from ethylene chloride, giving 7 g of chromatographically pure hydrocortisone with a melting point of 212-2.15.
The mother liquors are evaporated and the residue is taken up in 10 cubic meters of pyridine, 5 cm3 of acetic anhydride are added and the mixture is heated to 50 for 8 hours.
After the usual work-up, the reaction product is placed on a column which contains 20 g of Celite impregnated with ethylene glycol, that is to say a mixture of different pebbles known under this trade name. Elution with a mixture of 3 parts of cyclohexane and 1 part of methylene chloride gives 3.5 g of crystalline material.
Recrystallization from a little aqueous methanol gives 3 g of 4-pregnene -12ss, 17a, 21-triol-3.20-dione-12ss, 21-di-acetate. F. 155-157; E238 17 000; [a] D = + 122 (chloro form).
The elemental analysis confirms the composition of the compound. The mixed melting point with an authentic preparation (J. Chem. Soc. <I> 1955, </I> 870) does not give any depression. The JR spectra of both substances are practically identical.
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1216040X | 1958-02-13 | ||
| DESC023535 | 1958-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH369129A true CH369129A (en) | 1963-05-15 |
Family
ID=34913056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH6949459A CH369129A (en) | 1958-02-13 | 1959-02-12 | Method for introducing a hydroxyl group into the 12-position of Reichstein's compound S. |
Country Status (2)
| Country | Link |
|---|---|
| CH (1) | CH369129A (en) |
| FR (1) | FR1216040A (en) |
-
1959
- 1959-02-02 FR FR785574A patent/FR1216040A/en not_active Expired
- 1959-02-12 CH CH6949459A patent/CH369129A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR1216040A (en) | 1960-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1618599C3 (en) | Process for the production of 11 beta, 17 alpha, 21-trihydroxysteroids of the pregnane series | |
| Lavie et al. | Constituents of Citrullus colocynthis (L.) Schrad. | |
| CH369129A (en) | Method for introducing a hydroxyl group into the 12-position of Reichstein's compound S. | |
| AT230025B (en) | Method for introducing a hydroxyl group into the 12-position of Reichstein's substance S. | |
| US2686752A (en) | Enzymatic hydrolysis of steroidal saponins | |
| DE1049859B (en) | ||
| US2833792A (en) | 1, 3, 17-trioxygenated androstane derivatives | |
| DE1229522B (en) | Process for the preparation of cycloalkanols and / or cycloalkanones as well as esters of cycloalkanols | |
| US2659743A (en) | 11 alpha, 17 alpha, 21-trihydroxypregnane-3, 20-dione | |
| US3981867A (en) | Process for obtaining sapogenin particularly hecogenin from plant material such as agave sisalana leaves | |
| DE2318594C2 (en) | Process for the preparation of 2-substituted-3-alpha-hydroxy-5-oxo-1cyclopenten-1-heptanoic acid derivatives by stereospecific microbiological hydrolysis | |
| US2656370A (en) | 11 alpha-hydroxy-4-androstene-3, 17-dione | |
| DE948686C (en) | Process for the preparation of 4-pregnen-14ª ‡, 17ª ‡, 21-triol-3,20-dione | |
| CH495343A (en) | Process for the preparation of 13,14-dehydro-steroids | |
| DE1124945B (en) | Process for the production of 9ª ‡ oxysteroids of the Pregnan series | |
| DE1027667B (en) | Process for the production of polyoxygenated pregnanes | |
| DE834848C (en) | Process for the preparation of oxy compounds of the steroid series | |
| AT216153B (en) | Process for the production of oxygenated dehydrosteroids | |
| AT239967B (en) | Process for the preparation of 18,20 oxidosteroids | |
| Sorm | CORTISONE AND | |
| DE1135901B (en) | Process for the preparation of? -6ª ‡ -Fluoro- or -Chlor-16ª ‡ -alkyl-11ª ‡, 17ª ‡, 21-trihydroxy-pregnen-3, 20-diones and? -6ª ‡ -Fluor or -Chlor-16ª ‡ -alkyl-11ª ‡, 17ª ‡, 21-trihydroxy-pregnadiene-3, 20-dione | |
| DD266592A1 (en) | PROCESS FOR THE PREPARATION OF 11BETA, 15BETA-DIHYDROXY- (20S) -20-HYDROXYMETHYL-1,4-PREGNADIEN-3-ON | |
| CH331974A (en) | Process for the preparation of unsaturated 17-keto-steroids | |
| CH335489A (en) | Process for the production of a progesterone derivative | |
| CH330669A (en) | Process for the manufacture of 18-oxy-steroids |